RE: NIH seeks the next generation of COVID-19 diagnostics9 Sep 2022 10:58
I agree crowfoot. AS wrote on Jan 10th:
"We believe COVID-19 testing remains a long-term commercial opportunity. We will therefore use the robustness of the Affimer® platform, and what we have learned about the SARS-CoV-2 virus, to generate the next generation antigen test that will be as resilient as possible to any future mutations."